论文部分内容阅读
随着用甲胎蛋白(AFP)检测作普查以及肝扫描和腹腔动脉造影术的普遍开展,肝细胞癌的早期病例和切除例数都有了增加。然而,在非洲和东方与西方世界有所不同,肝细胞癌由于HbsAg阳性率高,常合并肝硬化和肝纤维化,从而使外科作肝切除术治疗受到限制。作者以日本京都大学医学部第一外科1966年1月至1978年5月手术切除的肝细胞癌30例作为研究对象。其中男性23例,女性7例;年龄27～71岁,平均年龄52.7岁;AFP阳性率为66.7%;HbsAg阳
With the widespread use of alpha-fetoprotein (AFP) testing for screening and liver scans and celiac arteriography, the number of early cases and resections of hepatocellular carcinoma has increased. However, in Africa and the East differ from the Western world, hepatocellular carcinoma is often associated with liver cirrhosis and hepatic fibrosis due to its high positive rate of HbsAg, thus restricting the surgical treatment of hepatectomy. The authors studied 30 cases of hepatocellular carcinoma surgically resected from January 1966 to May 1978 in the First Department of Medicine, Kyoto University, Japan. Among them, there were 23 males and 7 females; aged 27-71 years, mean age 52.7 years; AFP positive rate was 66.7%; HbsAg positive